Join the 2026 summit on CMT and hereditary neuropathy
The InternationalCMT-HNSummit2026 brings neurologists, geneticists, and researchers to Bengaluru for two days of evidence-driven sessions on Charcot-Marie-Tooth disease.
What will the 2026 summit actually change?
The summit's vision is to create a lasting shift in how CMT and hereditary neuropathy are studied and treated in Bengaluru and beyond. By 2026, we aim to establish a collaborative network that moves from gene-based classification to gene-based therapies, with measurable progress in patient care and research.
Led by clinicians who work with CMT and HN
The summit is organized by clinicians and researchers who stay close to the evidence, the patients, and the questions that matter in hereditary neuropathy. This committee shapes the full 2026 agenda.
Dr. Prabhudev Hiremath
Organizing Chair
Clinician with a focus on neuromuscular disorders in Bengaluru. Leads the summit program and ensures every session balances clinical depth with practical takeaway.
Dr. Ananya Rao
Scientific Committee Lead
Specialist in hereditary neuropathy genetics. Reviews abstracts and sessions to keep the 2026 program grounded in current evidence and emerging research.
Dr. Sanjay Menon
Program Coordinator
Paediatric neurologist guiding the multidisciplinary care track. Builds sessions that bring rehabilitation, clinical, and research perspectives into one room.
From Bengaluru to the global CMT community
The 2026 summit is built to connect specialists across disciplines and borders, with a program that spans the full arc of CMT and hereditary neuropathy care. Here is the scale we are working toward.
2
Intensive days
21 to 22 November 2026 in Bengaluru, packed with sessions and discussion.
8
Scientific sessions
From epidemiology to gene-based therapies, each session builds on the last.
150+
Clinicians and researchers
Neurologists, geneticists, paediatric specialists, and fellows expected to attend.
10+
Countries represented
An international faculty sharing evidence and clinical experience.
Two days. One shared mission.
From early planning conversations to the final agenda, clinicians and researchers have shaped every stage of the International CMT-HN Summit 2026. The program reflects what the community needs most.
This summit brings much-needed focus to CMT and hereditary neuropathy care across the region. The session lineup reflects real clinical priorities.
Dr. Anjali Rao
Consultant Neurologist, Bangalore
A dedicated forum for geneticists and neurologists to exchange evidence on gene-based therapies. A step forward for the field in India.
Dr. Vikram Iyer
Clinical Geneticist, Bengaluru
The multidisciplinary track on rehabilitation aligns with how we manage patients in practice. Looking forward to attending in November.
Dr. Meera Krishnan
Paediatric Neurologist, Chennai
Your abstract and participation shape the 2026 program.
Register for the 2026 summit and help shape the conversation on CMT and hereditary neuropathy in Bengaluru.